SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006671
Filing Date
2021-05-10
Accepted
2021-05-10 16:12:49
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20210331x10q.htm   iXBRL 10-Q 1051804
2 EX-31.1 omer-20210331xex31d1.htm EX-31.1 11336
3 EX-31.2 omer-20210331xex31d2.htm EX-31.2 12523
4 EX-32.1 omer-20210331xex32d1.htm EX-32.1 8105
5 EX-32.2 omer-20210331xex32d2.htm EX-32.2 7656
6 GRAPHIC omer-20210331x10q006.jpg GRAPHIC 27184
  Complete submission text file 0001558370-21-006671.txt   5503033

Data Files

Seq Description Document Type Size
7 EX-101.SCH omer-20210331.xsd EX-101.SCH 34597
8 EX-101.CAL omer-20210331_cal.xml EX-101.CAL 49952
9 EX-101.DEF omer-20210331_def.xml EX-101.DEF 121054
10 EX-101.LAB omer-20210331_lab.xml EX-101.LAB 369860
11 EX-101.PRE omer-20210331_pre.xml EX-101.PRE 273090
12 EXTRACTED XBRL INSTANCE DOCUMENT omer-20210331x10q_htm.xml XML 1073314
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 21907299
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences